1 Ocak 2017 Dergi makalesi Açık Erişim

Giris, Murat; Bireller, Sinem; Kucukali, Cem Ismail; Hanagasi, Hasmet; Degirmencioglu, Sevgin; Tuzun, Erdem

Dublin Core

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Giris, Murat</dc:creator>
  <dc:creator>Bireller, Sinem</dc:creator>
  <dc:creator>Kucukali, Cem Ismail</dc:creator>
  <dc:creator>Hanagasi, Hasmet</dc:creator>
  <dc:creator>Degirmencioglu, Sevgin</dc:creator>
  <dc:creator>Tuzun, Erdem</dc:creator>
  <dc:date>2017-01-01</dc:date>
  <dc:description>Introduction: Parenchymal neuro-Behcet disease (NBD) is encountered in 5%-15% of Behcet disease (BD) patients and is characterized by inflammation of the brainstem and diencephalon structures. Neuronal apoptosis has been shown to participate in neuronal cell loss. Anti-neuronal antibodies have been identified in NBD patients. However, the pathogenic properties of these antibodies have not been studied.</dc:description>
  <dc:identifier>https://aperta.ulakbim.gov.trrecord/46831</dc:identifier>
  <dc:identifier>oai:zenodo.org:46831</dc:identifier>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>http://www.opendefinition.org/licenses/cc-by</dc:rights>
  <dc:source>NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY 54(1) 67-71</dc:source>
  <dc:title>Impact of Neuro-Behcet Disease Immunoglobulin G on Neuronal Apoptosis</dc:title>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:type>publication-article</dc:type>
</oai_dc:dc>